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Background: Surgical treatment of clinically negative neck in maxillary squamous cell carci-
noma (SCC) of the upper jaw is controversial. The purpose of this study was to deﬁne the
incidence of cervical metastasis and to assess if elective neck dissection is justiﬁed when
the neck is not primarily affected.
Methods: We  retrospectively reviewed 20 patients treated of SCC of the maxillary alveolus
and  hard palate between 2005 and 2012.
Results: Six (30%) patients presented with cervical lymph metastasis at initial diagnosis.
Two  of the14 patients who initially had no signs of metastasis in the neck developed cervi-
cal  metastasis during follow-up and another patient with cervical metastasis at diagnosis
developed contralateral cervical metastasis. All the patients with cervical metastasis (45%)
were  pT3/T4 SCC. Cervical metastasis developed at a mean of 11.6 months.
Conclusions: Despite this study being limited by its retrospective nature and the sample size,
based on our ﬁndings and on an extensive review of the literature, we may conclude that
cervical metastasis from maxillary alveolus and hard palate SCC appears most frequently
in  pT3/T4 tumors. Therefore, we ﬁnd elective neck dissection appropriate for patients with
pT3/T4 SCC of the upper jaw.
©  2016 SECOM. Published by Elsevier España, S.L.U. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
¿Cual  es  el  papel  de  la  disección  cervical  electiva  en  el  carcinoma
escamoso  del  maxilar  superior?r  e  s  u  m  e  nPlease cite this article in press as: Moreno-Sánchez M, et al. What is the role of elective neck dissection in patients with squamous cell carcinoma
of the upper jaw? Rev Esp Cir Oral Maxilofac. 2016. http://dx.doi.org/10.1016/j.maxilo.2016.02.003
alabras clave:
isección cervical electiva
Introducción: El tratamiento quirúrgico del cuello clínicamente negativo en el carcinoma de
células escamosas (CCE) del maxilar superior es controvertido. El objetivo de este estudio es
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130-0558/© 2016 SECOM. Published by Elsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license
http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Carcinoma de células escamosas
Maxilar superior
Tratamiento quirúrgico
Metástasis cervical linfática
mostrar la incidencia de metástasis cervical y analizar si la disección cervical electiva está
justiﬁcada cuando el cuello no está afectado de inicio.
Métodos: Revisamos retrospectivamente 20 pacientes tratados por CCE de paladar duro y
reborde alveolar superior entre 2005 y 2012.
Resultados: Seis (30%) pacientes presentaron metástasis cervical de inicio. Dos de los
14  pacientes que inicialmente no tuvieron signos de metástasis cervical la desarrollaron
durante el seguimiento, y otro paciente con metástasis cervical al inicio desarrolló una
metástasis cervical contralateral. Todos los pacientes con metástasis cervical (45%) fueron
pT3/T4 CCE. El tiempo medio de aparición de metástasis cervical fue de 11,6 meses.
Conclusiones: A pesar de las limitaciones de este estudio (naturaleza retrospectiva, limi-
tado  número de pacientes), y tras analizar los resultados obtenidos y revisar la literatura,
podemos concluir que la metástasis cervical de CCE de maxilar superior aparece con mayor
incidencia en tumores pT3/T4. Por lo tanto, creemos conveniente realizar disección cervical
electiva en pacientes con CCE T3/T4 de maxilar superior.
©  2016 SECOM. Publicado por Elsevier España, S.L.U. Este es un artículo Open Access
cia Cbajo la licen
Introduction
Squamous cell carcinoma (SCC) is the most common malig-
nant type of carcinoma within the oral cavity. Maxillary and
mandibular gingivae are ﬁlled with lymph systems that cross
the midline. In the same way, mucosa of the hard and soft
palate is streaked by a dense superﬁcial system of lymph
vessels. It is well documented that SCC with a mucosal ele-
ment has potential risk to metastasize to cervical lymph
nodes, especially in cervical levels I and II. The involvement of
regional lymph nodes depends on factors such as site, tumor
size and several histological features of the primary tumor, as
previously reported.1–3
Maxillary SCC is less frequent than SCC from other oral
sites such as tongue, ﬂoor of mouth or retromolar region. Many
studies have evaluated the need for elective neck dissection
for these intraoral common sites when there is no clinical
or radiological suspicious of lymphadenopathy. Controver-
sies remain regarding the strategy of treatment for patients
with maxillary SCC, including indications for unilateral or
bilateral elective neck dissection and postoperative adjuvant
treatment. Only a few authors4–13 have focused on the man-
agement of the neck in SCC of the maxillary gingiva, maxillary
alveolus and hard palate.
In general, tumors with cervical lymph node metastasis
are associated with increased risk of treatment failures and
recurrences. In recent studies,5,10 it has been proven that a
high rate of occult cervical metastasis in SCC of the maxilla
has been found and elective neck dissection in these patients
was recommended in order to reduce recurrences.
The aim of this retrospective study was to determine the
rate of cervical lymph node metastasis from the upper maxil-
lary alveolus and hard palate SCC. We also wondered if elective
neck dissection should be considered for SCC of the maxil-
lary alveolus and hard palate when the neck is not primarily
affected.
Materials  and  methodsPlease cite this article in press as: Moreno-Sánchez M, et al. What is the role
of the upper jaw? Rev Esp Cir Oral Maxilofac. 2016. http://dx.doi.org/10.101
A retrospective study of medical records was carried out using
database of oncological patients of the Department of oralC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
and maxillofacial surgery. Twenty patients treated of maxillary
SCC involving the alveolus and hard palate between 2005 and
2012 were included in this study. All of these patients received
a complete clinical head and neck examination, including
ﬁberscope examination. A biopsy of the surgical specimen was
performed before surgery for diagnostic purposes. Magnetic
resonance imaging (MRI) and/or computed tomography (CT)
scan was performed before surgery, in order to assess tumor
radiologic features, tumor extension and also involvement of
neighboring structures, if present.
Inclusion  criteria
Twenty patients presenting SCC of the maxilla met  the follow-
ing inclusion criteria:
1. Tumors diagnosed as SCC at the examination of patholog-
ical features of the surgical specimens obtained by biopsy.
2. Tumors located at maxillary gingiva, maxillary alveolus
and hard palate.
3. Tumors that were not originated in paranasal sinuses or
the nasal cavity shown by the examination from radiologic
tests. Tumors involving these sites and other malignancies
of the maxilla were excluded from this study.
Treatment  considerations
Surgery consisted on resection of the primary tumor with
at least a 1-cm margin around the lesion. All patients with
possible lymph neck node metastasis from the physical and
radiologic examination were considered clinically positive
neck (cN+), and were subsequently submitted for a modiﬁed
type III radical neck dissection of the involved side. If no posi-
tive cervical lymph nodes were pre-operatively demonstrated,
cervical dissection was not performed. Patients with tumors
that cross the midline were operated, performing cervical neck
dissection when neck was clinically or radiologically positive.
Local-regional post-operative RT was also administered of elective neck dissection in patients with squamous cell carcinoma
6/j.maxilo.2016.02.003
if at least one of the following criteria was present: close
(1–5 mm)  or involved (<1 mm)  surgical margins, vascular inva-
sion, perineural inﬁltration, bone or cartilage involvement
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Fig. 1 – Survival curve (Kaplan–Meier) for patients treatedr  e v e s p c i r o r a l m a x i l
nd/or pathologic lymph neck node involvement (pN+) after
istologic examination of the surgical specimen.
Registered treatment features (Table 1) were: (1) lymph
eck node extension at diagnosis; (2) type of surgical treat-
ent; and (3) administration of post-operative radiotherapy.
istologic  features
ll the surgical specimens were analyzed and revised specif-
cally for this study by the Department of Pathology of our
nstitution. A complete supply of histologic information was
ncluded in our records (Table 1), such as: (1) pathological TNM
taging (pTNM); (2) tumor grading; (3) tumor margins: free
>5 mm),  close (1–5 mm);  involved (<1 mm)  bone involvement:
4) vascular invasion; and (5) perineural inﬁltration.
ollow-up
ll patients underwent a CT-scan at 6 months and at one
ear after surgery as a control for regional recurrence or cervi-
al metastasis. As long as regional recurrence was suspected,
 cervicofacial CT-scan with or without positron-emission-
omography (PET)-CT scan and a cytological study using
ne-needle aspiration (FNA) of the cervical mass were per-
ormed.
Registered follow-up features were: (1) presence of regional
ecurrence; and (2) clinical outcome at the end of the follow-up
eriod.
This study was approved by the Hospital Ethical Committee
nd by the Institutional Human Studies (IRB) Committee.
ata  analysis
ata analysis was performed by using SPSS® software for Win-
ows (version 21.0; IBM®, Chicago, IL). The level of statistical
igniﬁcance was set at 0.5. The descriptive statistical analysis
as based on the mean and standard deviation for contin-
ous variables, whereas the frequency and percentage were
sed for categorical variables.
esults
he study group included 20 patients, 12 men  and 8 women,
ith SCC of the maxilla and with an average age of 67.65
ears at initial diagnosis. Data regarding tumor location,
umor staging, pathological features, performed treatment
nd appearance of regional recurrence are depicted in Table 1.
verage post-operatory follow-up was 53.25 months. Thirteen
atients (65%) had tumors primarily located in the hard palate,
hereas 7 patients (35%) had them in the maxillary alveo-
us. Tumor grade was well-differentiated in 12 (60%) of the
atients, while it was moderately-differentiated in 8 (40%).
erineural inﬁltration was present in 3 (15%) patients, while
ascular invasion appeared in 5 (25%). Bone involvement was
dentiﬁed in 8 (40%) patients. Regarding tumor size, pTNMPlease cite this article in press as: Moreno-Sánchez M, et al. What is the role
of the upper jaw? Rev Esp Cir Oral Maxilofac. 2016. http://dx.doi.org/10.101
lassiﬁcation revealed advanced disease in 11 (55%) patients,
hence tumors were classiﬁed as pT3 and pT4.
Fourteen patients (70%) did not undergo cervical manage-
ent, 6 (30%) underwent a modiﬁed type III radical neckfor SCC of the maxilla.
dissection plus post-operative RT. Post-operative local RT was
administered in 13 patients (65%).
At diagnosis, 6 of the 20 (30%) patients with maxillary
SCC presented cervical nodal disease, as evidenced by clinical
examination and radiological ﬁndings consistent with malig-
nancy. Five of these six patients had bone invasion. These
six patients underwent cervical dissection and the patho-
logical examination showed lymph neck node metastasis in
all of them. Interestingly, they were also classiﬁed as pT3
and pT4 from the histological study of the surgical specimen
attending to tumor size considerations and bone invasion.
Among these patients, no regional recurrence in the ipsilat-
eral neck appeared during the follow-up period. Meanwhile,
3 of the 20 (15%) patients developed cervical metastasis in
the follow-up period (these 3 patients had bone invasion): (1)
Two patients at 10 and 11 months, in the contralateral neck;
(2) one patient at 14 months in the ipsilateral neck. Cervical
metastasis developed at 11.6 months as average time. Local
recurrence appeared in 2 of 20 (10%) patients. In this series,
9 of the 20 (45%) patients with SCC involving the palate or
the maxillary alveolus developed cervical metastasis during
disease, including those present at initial diagnosis (30%) and
those appearing during follow-up (15%).
In this series, the 2-year survival rate for patients suffer-
ing SCC of the maxilla was 79%, while the 5-year survival rate
decreased to 69% (Fig. 1).
Discussion
In the last century, few studies have been focused on cervical of elective neck dissection in patients with squamous cell carcinoma
6/j.maxilo.2016.02.003
metastasis from SCC of the maxilla. Nevertheless, cervical
metastasis from SCC of the tongue or the ﬂoor of mouth has
been well studied, both sites presenting a high incidence.14,15
Janeway, in 1918, ﬁrst reported cervical metastasis from
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Table 1 – Patient’s data (maxillary alveolus and hard palate squamous cell carcinoma).
Age Tumor
location
cTNM Metastasis at
diagnosis
Tumor
margins
Histological
grade
Perineural
inﬁltration
Vascular
invasion
Bone
involvement
pTNM  Regional
treatment
Local rt post-
operative
Cervical
metasta-
sis
Follow-up
(months)
Patient
status
63 Hard palate T2N0M0 No CLEAR Well-differentiated No No No T2N0M0 None No No 28 NED
71 Hard palate T1N0M0 No CLEAR Well-differentiated No No No T1N0M0 None No No 32 NED
81 Maxillary
alveolus
T2N0M0 No INV Well-differentiated No No Yes T4aN0M0 None Yes No 36 NED
59 Hard palate T4N2bM0 Yes INV Well-differentiated No Yes Yes T4aN2bM0 MRD/RT Yes CL 14 DOD
83 Hard palate T3N2bM0 Yes CLEAR Moderately-
differentiated
No  Yes Yes T4aN2bM0 MRD/RT Yes No 45 NED
77 Maxillary
alveolus
T1N0M0 No CLEAR Well-differentiated No No No T1N0M0 None No No 48 NED
59 Maxillary
alveolus
T3N0M0 No INV Moderately-
differentiated
Yes No Yes T4aN0M0 None Yes CL 41 DOD
77 Hard palate T2N0M0 No CLEAR Well-differentiated No No No T2N0M0 None No No 56 NED
54 Hard palate T2N0M0 No CLOSE Well-differentiated No No No T2N0M0 None Yes No 72 NED
82 Hard palate T1N0M0 No CLOSE Well-differentiated No No No T1N0M0 None Yes No 73 NED
75 Hard palate T2N0M0 No CLEAR Well-differentiated No No No T2N0M0 None No No 12 DOD
57 Maxillary
alveolus
T2N0M0 No INV Moderately-
differentiated
No  No No T2N0M0 None Yes No 56 NED
87 Maxillary
alveolus
T4N0M0 No INV Well-differentiated No No No T4N0M0 None Yes No 17 DOD
68 Maxillary
alveolus
T4N1M0 Yes INV Well-differentiated No Yes Yes T4aN1M0 MRD/RT Yes No 60 NED
62 Hard palate T4N0M0 No CLEAR Moderately-
differentiated
No  No No T4N0M0 None Yes No 73 NED
55 Hard palate T3N2bM0 Yes CLEAR Well-differentiated No No No T3N2bM0 MRD/RT No No 86 NED
56 Hard palate T3N1M0 Yes CLEAR Moderately-
differentiated
Yes Yes Yes T4aN1M0 MRD/RT Yes No 100 NED
59 Hard palate T4N0M0 No INV Moderately-
differentiated
Yes No Yes T4aN0M0 None Yes (only 5
sessions)
IL 89 NED
63 Hard palate T2N0M0 No CLEAR Well-differentiated No No No T2N0M0 None No No 32 NED
65 Maxillary
alveolus
T3N1M0 Yes CLEAR Moderately-
differentiated
No  Yes Yes T4aN0M0 MRD/RT Yes No 95 NED
Abbreviations: INV, involvement; MRD, modiﬁed radical neck dissection; RT, radiotherapy. NED, no evidence of disease; DOD, died of disease; CL, contralateral; IL, ipsilateral.
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axillary SCC on a rate of 33.3% (7/21), while most of patients
ere treated with radiotherapy.16
In our series, 9 of the 20 (45%) patients with SCC involv-
ng the palate or the maxillary alveolus developed cervical
etastasis during disease, including those present at initial
iagnosis (30%) and those appearing during follow-up (15%).
hese outcomes are similar to others published in recent stud-
es. Montes and Schmidt,4 in a series of 14 patients with SCC
f the maxilla, reported a 42.9% rate of regional nodal dis-
ase. Brown et al.5 in a series of 43 patients, reported a rate
f 37.2% of cervical metastasis. Simental et al.6 in a series of
6 patients with SCC of the maxillary alveolus and hard palate
ound cervical metastasis in 34.6%, similar to that observed by
ruse and Grätz7 (33.6%) in a series of 30 patients. Mourouzis
t al.8 reported a 23.5% incidence of cervical metastasis at pre-
entation with maxillary SCC in a series of 17 patients. These
eported incidences of cervical metastasis are comparable to
hose observed for SCC of the tongue or the ﬂoor of mouth.
gura et al.9 reported a 28.5% incidence of cervical disease at
resentation. In this study, they found a signiﬁcant relation-
hip between the presence of bone invasion and the presence
f cervical metastasis. In our study, we  observed the pres-
nce of bone invasion in 8 patients. Seven of these 8 (87.5%)
atients developed cervical metastasis, including those found
t presentation (5 patients) and those found during follow-up
2 patients).
Interestingly, in our study two of the three cervical metas-
asis occurred in the contralateral neck during follow-up.
 possible explanation for that higher observed contralat-
ral neck metastasis in SCC of the maxilla compared with
ther locations within the oral cavity could be due to the
act that the mucosa of the hard palate has a dense super-
cial lymphatic vessel system. A few crossing lymph vessels
re located in the midline of the hard palate, and a signiﬁ-
ant transition of the midline can be observed in the deeper
nd the caudal part of the soft palate. Due to this, contralat-
ral regional recurrence from SCC of the hard palate and
axillary alveolus could be probably present in lesions cross-
ng the midline,17 being this a yet non-evidenced contrasted
ypothesis.
In our series, neck metastasis developed at 11.6 months
s average time. No regional recurrence appeared during the
ollow-up period. Simental et al.6 and Montes and Schmidt4
eported regional recurrences at 10.4 and 9.75 months, respec-
ively, whereas Morris et al.10 pointed it out at 6 months.
resumably, most of regional recurrences may appear during
he ﬁrst year. Therefore, close monitoring should be kept over
hese patients.
It  is very signiﬁcant that all cervical metastasis from SCC
f the maxilla in this series (45%) corresponded with a tumor
ize larger than 4 cm (T3 and T4 tumors). This rate of cervi-
al metastasis from big-sized tumors may suggest performing
lective neck dissection only in patients with advanced dis-
ase. This ﬁnding has also been observed by an American
ulticenter study by Montes et al.11 about maxillary SCC,
hich reported a high percentage of cervical metastasis in
3 and T4 tumors. Meng et al.18 in their series of 78 patientsPlease cite this article in press as: Moreno-Sánchez M, et al. What is the role
of the upper jaw? Rev Esp Cir Oral Maxilofac. 2016. http://dx.doi.org/10.101
ith SCC of the maxilla, reported that rates for positive nodal
etastasis from T1 and T2 tumors were lower than 15%,
hereas those for T3 and T4 tumors were higher than 40%. . 2 0 1 6;x x x(x x):xxx–xxx 5
Analyzing pathological features, moderately differentiated
SCC was present in 71.4% of all the patients who  presented
or developed cervical metastasis.
Weiss et al.19 advised performing elective treatment of the
neck in patients with SCC of the oral cavity when risk of clin-
ically occult metastasis exceeded 15–20%. Recently, several
studies have been published reporting higher-than-expected
incidence of regional recurrence in patients without neck
metastasis at diagnosis, ranging from 14% to 29%,4–11 which
resulted in poor survival in most of the cases. Morris et al.10
reported a 21% of isolated regional recurrence rate and they
suggested that elective neck dissection would seem prudent
in most locally advanced cases. The rate of cervical metasta-
sis in our study was 45% (9 of 20). Based on these ﬁndings and
in our results, we emphasize the importance of considering
elective neck dissection in the treatment of locally advanced
SCC of the maxilla.
Brown et al.5 suggested that management of the N0 neck
for maxillary SCC should include the same approach to the
neck than to other oral sites. They carried out a compari-
son between SCC in the maxillary alveolus and hard palate
to other oral sites in terms of neck management and out-
comes. They reported a higher regional recurrence rate (26%)
in tumors of the maxillary alveolus and hard palate compared
with tumors from other oral sites (7%). This could be due to
the fact that elective neck dissection was performed in 55%
of patients with tumors in other sites of the oral cavity while,
in contrast, in only 28% of patients with tumors in the upper
maxilla.
This study has some limitations since it is a retrospec-
tive study with a short number of patients. Despite that,
it is pointed out the high incidence of cervical metastasis
from SCC of upper maxilla, especially in cases of advance
stages.
All these studies add evidence of a need in changing the
management of the N0 neck in maxillary SCC. Not only elec-
tive neck dissection is an option in cN0 patients, but also other
treatments such as sentinel node biopsy.
Conclusions
Despite this study is limited by its retrospective nature and the
sample size, and based on our ﬁndings and on an extensive
review of the literature, we  may conclude that cervical metas-
tasis from maxillary alveolus and hard palate SCC appears
most frequently in pT3/T4 tumors and in presence of bone
invasion. Therefore, we recommend elective neck dissection
for patients with pT3/T4 SCC of the maxillary alveolus and the
hard palate.
Ethical  responsibilities
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